| 发明名称 |
USE OF RPN2 GENE EXPRESSION INHIBITOR |
| 摘要 |
The present invention uses an RPN2 gene expression inhibitor as a cancer cell growth inhibitor, which further includes a drug showing an anti-cancer action if desired, and is administered in combination with atelocollagen if desired. In addition, the present invention is an anti-cancer agent including such cancer cell growth inhibitor. |
| 申请公布号 |
EP2047864(A4) |
申请公布日期 |
2010.12.01 |
| 申请号 |
EP20070766944 |
申请日期 |
2007.06.15 |
| 申请人 |
TAISHO PHARMACEUTICAL CO., LTD;KOKEN CO., LTD.;DAINIPPON SUMITOMO PHARMA CO., LTD.;JAPAN AS REPRESENTED BY PRESIDENT OF NATIONAL CANCER CENTER |
发明人 |
OCHIYA, TAKAHIRO;KATO, KIKUYA;HONMA, KIMI;UEDA, YASUJI |
| 分类号 |
A61K45/00;A61K31/282;A61K31/337;A61K31/713;A61K45/06;A61K47/42;A61K48/00;A61P13/08;A61P35/00;A61P35/02;A61P43/00;C12N15/113 |
主分类号 |
A61K45/00 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
